Preanalgesic Effect of Gabapentin in Total Knee Repair
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00279487|
Recruitment Status : Completed
First Posted : January 19, 2006
Last Update Posted : October 26, 2016
|Condition or disease||Intervention/treatment||Phase|
|Pain||Drug: Gabapentin Drug: Placebos||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||24 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Preanalgesic Effect of Gabapentin in Total Knee Repair|
|Actual Study Completion Date :||August 2007|
Active Comparator: Arm 1
Patients will receive 1200mg gabapentin 1-2 hours prior to surgery.
Placebo Comparator: Arm 2
Patients will receive placebo 1-2 hours prior to surgery.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00279487
|United States, Texas|
|Presbyterian Hospital of Dallas|
|Dallas, Texas, United States, 75231|
|Principal Investigator:||Rob Hutchison||Texas Health Resources|